Show simple item record

dc.contributor.authorSohail, A
dc.contributor.authorVan Leer, L
dc.contributor.authorHolmes, N
dc.date.accessioned2020-12-22T05:02:38Z
dc.date.available2020-12-22T05:02:38Z
dc.date.issued2017-03-04
dc.identifierpii: 10.1186/s13104-017-2438-7
dc.identifier.citationSohail, A., Van Leer, L. & Holmes, N. (2017). An unexpected diagnosis of human immunodeficiency virus-2 infection in an overseas visitor: a case report.. BMC Res Notes, 10 (1), pp.116-. https://doi.org/10.1186/s13104-017-2438-7.
dc.identifier.issn1756-0500
dc.identifier.urihttp://hdl.handle.net/11343/258197
dc.description.abstractBACKGROUND: Human immunodeficiency virus 2 infection is endemic in West Africa but is also found in parts of Europe, North and South America, and India where it is thought to have been introduced secondary to migration and commercial trade ties. It is less common than Human immunodeficiency virus 1, with differences in pathogenicity, lower rates of transmission, longer asymptomatic period and slower progression to acquired immunodeficiency syndrome. Human immunodeficiency virus 2 is also associated with diagnostic challenges given the lack of commercially available diagnostic tests, and management challenges given intrinsic resistance to many anti-retroviral therapies. CASE PRESENTATION: We describe a case of a 65 year old South Indian female, visiting her family in Australia, who presented with weight loss, pancytopaenia and generalised lymphadenopathy on a background of newly diagnosed congestive cardiac failure. Multiple investigations were performed to elucidate the cause of her presentation, with the eventual unexpected diagnosis of human immunodeficiency virus 2. She was commenced on anti-retroviral treatment and made a remarkable recovery. CONCLUSION: We describe the challenges associated with diagnosis of human immunodeficiency virus 2 due to lack of commercially available diagnostics, as well as the treatment and management challenges including the fact that human immunodeficiency virus 2 is intrinsically resistant to non-nucleoside reverse transcriptase inhibitors. Human immunodeficiency virus 2 infection should be considered in patients who present with symptoms and signs that do not point towards a clear diagnosis, such as unexplained pancytopaenia or lymphadenopathy, and who have risk factors such as being from an endemic area or having had blood transfusions, especially prior to the commencement of blood-borne virus screening of blood donors.
dc.languageeng
dc.publisherSpringer Science and Business Media LLC
dc.titleAn unexpected diagnosis of human immunodeficiency virus-2 infection in an overseas visitor: a case report.
dc.typeJournal Article
dc.identifier.doi10.1186/s13104-017-2438-7
melbourne.affiliation.departmentMedicine and Radiology
melbourne.source.titleBMC Research Notes
melbourne.source.volume10
melbourne.source.issue1
melbourne.source.pages116-
dc.rights.licenseCC BY
melbourne.elementsid1190861
melbourne.openaccess.pmchttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336689
melbourne.contributor.authorHolmes, Natasha
dc.identifier.eissn1756-0500
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record